echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Nature Communications: New Discovery of Diagnostic Markers for Rheumatoid Arthritis

    Nature Communications: New Discovery of Diagnostic Markers for Rheumatoid Arthritis

    • Last Update: 2021-08-12
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Li Zhanguo's research team reveals new discoveries of diagnostic marker molecules for rheumatoid arthritis

     


     

    Screenshot of the paper

    A training and validation cohort study was conducted on this subject, and a total of 3,262 patients were enrolled.


    RA is one of the most common diseases in autoimmune diseases.


    This project was completed by Professor Li Zhanguo's research group, Xiang-Yang Wang of Virginia Commonwealth University, Wang Yongfu of Baotou Medical College, Wu Huaxiang of Zhejiang University, and Li Juan of Southern Medical University


     

     

     

     



    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.